Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
The Middle East conflict: pharma’s supply chain stress test
The conflict is disrupting critical air freight routes, exposing vulnerabilities for biologics and low-margin generics.
Read more
Conquering generational differences in HCP marketing
What are the generation differences in how HCPs want to talk to pharma? Three generations of doctors share their thoughts.
Mina Makar on tackling unmet patient needs
AstraZeneca’s Mina Makar talks about solving unmet needs and how to champion the patient perspective.
The Twitter scandal that scared off pharma marketers
Many top pharma companies have cut their Twitter ad spend after the Eli Lilly scandal, but should they take a risk and return?
5 ways pharma can ensure omnichannel success
Roche’s Davidek Herron offers five top tips for pharma teams striving for omnichannel excellence.
Tipping the scales of KOL success
How can pharma maximise the impact of key opinion leaders in the ever-evolving digital world?
Mastering medical affairs
Medical affairs is becoming increasingly complex, but industry-academia collaboration aims to tackle this head on.
The brains behind neurological breakthroughs
The recent approval of lecanemab is a win for Alzheimer’s patients, but how can pharma ensure access?
Pharma in Poland
Travel to Poland to discover the factors driving its pharmerging status and access to medicine challenges.
Loading posts...
« Previous
1
…
11
12
13
14
15
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View